Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;47(11):1791-1797.
doi: 10.1111/1440-1681.13395. Epub 2020 Sep 9.

Hypothesis: The potential therapeutic role of nicorandil in COVID-19

Hend Ashour  1   2 , Mohamed H Elsayed  3   4 , Soha Elmorsy  5 , Inas A Harb  5
Affiliations
Review

Hypothesis: The potential therapeutic role of nicorandil in COVID-19

Hend Ashour et al. Clin Exp Pharmacol Physiol. 2020 Nov.

Abstract

At present, there is yet no specific antiviral treatment or immunization against the newly identified human severe acute respiratory syndrome virus (SARS-CoV2) that results in a rapidly progressive pandemic coronavirus disease 2019 (COVID-19). We believe in a crucial need for a clinical strategy to counteract this viral pandemic based on the known pathogenesis throughout the disease course. Evidence suggests that exaggerated patient's inflammatory response and oxidative stress are likely to aggravate the disease pathology. The resulting endothelial dysfunction further induces fibrosis and coagulopathy. These disturbances can generate severe acute respiratory distress syndrome (ARDS) that can progress into respiratory and circulatory failure. Nicorandil is an anti-anginal vasodilator drug acts by increasing nitric oxide bioavailability and opening of the KATP channel. Recently, nicorandil has been recognized to possess multiple protective effects against tissue injury. Here, we address a possible modulatory role of nicorandil against COVID-19 pathogenesis. We hypothesise nicorandil would be an effective form of adjuvant therapy against COVID-19.

Keywords: COVID-19; anti-coagulation; anti-fibrosis; anti-inflammatory; anti-oxidative; nicorandil.

PubMed Disclaimer

Conflict of interest statement

The authors declare that there are no conflicts of interest.

Comment in

References

    1. Alhazzani W, Møller MH, Arabi YM, et al. Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID‐19). Intens Care Med [Internet]. 2020;46(5):854‐887. Available from http://link.springer.com/10.1007/s00134‐020‐06022‐5 - DOI - PMC - PubMed
    1. Huang C, Wang Y, Li X, Ren L, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The Lancet. 2020;395(10223):497–506. 10.1016/s0140-6736(20)30183-5 - DOI - PMC - PubMed
    1. Organization WH .COVID‐19 CORONAVIRUS PANDEMIC [Internet]. Vol. 3, The Journal of Health Technology Assessment. 2020. Available from: https://www.worldometers.info/coronavirus/
    1. Hamming I, Timens W, Bulthuis M, Lely A, Navis G, van Goor H. Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. J Pathol [Internet]. 2004;203(2):631‐637. Available from: http://doi.wiley.com/10.1002/path.1570 - DOI - PMC - PubMed
    1. Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS. Angiotensin‐converting enzyme 2 (ACE2) as a SARS‐CoV‐2 receptor: molecular mechanisms and potential therapeutic target. Intens Care Med [Internet]. 2020;46(4):586‐590. Available from http://link.springer.com/10.1007/s00134‐020‐05985‐9 - DOI - PMC - PubMed

MeSH terms